COMPANY

Novian Health

Keywords: oncology tumors Malignant Neoplasm of Breast Novilase Laser ablation Novilase Interstitial Laser Therapy

Location: Chicago, IL · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Aug 9, 2023 Trial start Not phased (device or behavioral study): Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors source ↗
2012-04 Trial start Not phased (device or behavioral study): A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers source ↗
2008-12 Trial start —: American Breast Laser Ablation Therapy Evaluation source ↗

Dec 31, 2026 (ESTIMATED) · Not phased · Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors · NCT03463954

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT03463954	Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors	Not phased (device or behavioral study)	Recruiting	Aug 9, 2023	Dec 31, 2026 (estimated)
NCT00807924	American Breast Laser Ablation Therapy Evaluation	Not listed	Completed	2008-12	Aug 28, 2017 (actual)
NCT01478438	A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers	Not phased (device or behavioral study)	Unknown status (ClinicalTrials.gov)	2012-04	2015-12 (actual)